Background: Single cell RNA sequencing provides unprecedented opportunity to simultaneously explore the transcriptomic and immune receptor diversity of T and B cells. However, there are limited tools available that simultaneously analyse large multi-omics datasets integrated with metadata such as patient and clinical information.
Background
Immunological studies have revealed a surprisingly high level of heterogeneity between immune cells, even in those with same clonotype and surface phenotype, suggesting that lymphocyte populations of apparently similar phenotype could have different functions [1] . With the advent of single cell RNAsequencing (scRNA-seq), it is now possible to unravel the heterogeneity of T and B cells and link receptor clonotype diversity to the gene expression profile of each cell and to clinical or other metadata.
Multi-modality single cell datasets are rapidly pervading in medical research, and are being used to identify novel cellular states and molecular features of diseases [2] [3] [4] , to extract information on the DNA (mutations, methylation), mRNA (gene expression profiles) and to further study the heterogeneity of immune cells of apparently similar clonotype and phenotype [3] .
With the recent availability of scRNA-seq derived clonal and transcriptomic data, several software packages have been developed for the downstream analyses of these data types [3] . For instance software packages such as TRACER [5] BRACER [4] and VDJPuzzle (for both TCR [6] and BCR [2] ) can accurately identify the full-length TCR and BCR from the sequenced cDNA. A vast set of tools are already available to perform gene expression analysis, including clustering, differential expression, dimensionality reduction, trajectory inference, and gene signature identification (e.g. https://www.scrna-tools.org/). More recently, epitope barcoding on cell surface has been also integrated with scRNA-seq, further highlighting the importance of multi-modal single cell technologies [7, 8] .
Integrating these levels of genomic information can be important to fully decipher the changes of immune cells during immune response, or to identify subsets of rare cells with specific phenotypes.
Tools that integrate several of the available methods to analyse single cell transcriptomics have been proposed [9, 10] . Additionally, it is often necessary to link this information with clinical and other metadata, for instance with the tissue origin, surface phenotype (e.g. flow cytometry data at the time of index sorting), or with the sample origin and disease diagnosed. To date, there are limited software packages that are accessible to non-bioinformatics experts, and that allow simultaneous analysis of gene expression, immune receptors and notably clinical and other metadata. For instance, Loupe Cell Browser 3.1 from 10X Genomics provides users with a first line of analysis to explore gene expression and annotate their dimensionality reduction plots with immune receptor information. However, such tools do not permit extensive analysis of the data, such as hypothesis testing and integration of metadata into differential expression or immune receptor analyses. Additionally, such tools usually have strict input requirements, with Loupe Cell Browser 3.1 not allowing users to analyse datasets from different technologies, such as plate-based sorting, which remains a common technology of choice to study immune repertoires.
Multi-layer analyses often require lengthy integration of bioinformatics and biological skills.
Experience with software tools, such as R, is often a barrier to entry, with most of the data manipulation, visualisation and package integration being left to the user. To properly answer and address biological questions, multiple packages need to be complemented with ad hoc scripts that modify input data, filter cells and then test hypotheses, which is a source of latency between the biologist and the bioinformatician. Here, we report a novel bioinformatics tool, VDJView, which delivers an integrated set of novel and publicly available tools to analyse and visualise the clonal and transcriptomic data with clinical and metadata. The shiny app, VDJView, addresses the drawbacks in currently available multi-omics analysis tools, by removing the need for a skilled bioinformaticians, allowing researchers to test hypotheses and explore the relationship between multi-modal single cell datasets.
Implementation
VDJView is an R Shiny web-application developed for the analysis of clonal and transcriptomic single-cell data (Figure 1 ). The intuitive graphical user interface allows researchers with or without computational training to interactively analyse and explore their datasets, interrogating the results against user uploaded cell metadata. VDJView acts as a wrapper for commonly used transcriptomic and receptor analysis packages (Table 1) , integrating them and allowing the user to generate and manipulate figures and tables. The plots generated are exportable to publication-quality pdf files, and all tables can be downloaded in CSV format. VDJView has been extensively tested on Linux and MacOS, with most features functional on Windows as well, and has the sole requirement of an R version of at least 3.4.1 being installed. VDJView has been tested on multiple datasets available from published literature using SmartSeq2 and 10X libraries (see below). The performance of the application is detailed in Supplementary Note 1. shows the inferred evolutionary trajectory between all immune cells determined by genes that differentiate primary from metastatic tissues in two subjects with matched samples.
VDJView input data
Pre-analysed scRNA-seq data can be directly uploaded into VDJView. The three data types that VDJView accepts are; T and/or B cell receptor data, gene expression data, and metadata. Immune receptor data can be uploaded as a list in csv or other tabular formats. Gene expression data can be uploaded as a matrix of expression counts per cell or other common formats including those generated by the 10X Cell Ranger kit. Metadata can be uploaded in csv format. VDJView can also be pipelined with computational tools that generate gene expression and immune receptor sequencing from raw data, allowing users to use their own workflow. Here, we have tested VDJView with scRNA-seq data available publicly and generated by high-throughput 3' or 5' end technologies, 10X and SmartSeq2 data.
Datasets analysed
1. SmartSeq2 breast cancer T and B cells, N = ~560 [11] 2. 10X CD8+ T cells, N = ~150,000 (https://www.10xgenomics.com/resources/applicationnotes/a-new-way-of-exploring-immunity-linking-highly-multiplexed-antigen-recognition-toimmune-repertoire-and-phenotype/)
10X non-small lung cancer cells (NSCLC), N = ~8,300
(https://support.10xgenomics.com/single-cell-vdj/datasets/2.2.0/vdj_v1_hs_nsclc_5gex)
Hepatocellular carcinoma T cells, N = ~4800 [12]

VDJView features and modules
VDJView integrates multiple R software packages to provide a powerful yet cohesive repertoire of analysis modules (Table 1) . Numerous interactive and customizable figures are provided for the analysis of clonotype data, and further modules are available for the simultaneous or isolated exploration of expression data. All figures and tables are updated automatically if any of the relevant parameters are changed during the analysis. Further details and a complete list of features can be found in Supplementary Note 1. 
Results
Analysis of SmartSeq2 breast cancer cells
To demonstrate the utility and novelty of VDJView, we analysed scRNA-seq data (full-length transcriptome, SmartSeq2 protocol) from the primary breast tissues and metastatic lymph nodes of 11 subjects [11] . We applied VDJPuzzle [2] to the scRNA-seq data to quantify the gene expression and through gene enrichment analysis [11] . In addition to these, we found 33 cells with TCR and BCR chains, suggesting that they were likely contaminants or doublets. While our analysis of the T cells revealed a highly diverse repertoire ( Supplementary Figure 1) , we identified a clone in BC03 which was present in both primary and metastatic lymph node tissues, as well as 31 B-cell clones, with clonotypes shared across primary and metastatic tissues, and across subjects (Figure 1 and Supplementary Figures 1-2 , Supplementary Tables 1-2 ). Pseudo-time analysis on these immune cells showed that a common repertoire of B cells is involved in breast cancer with a migratory pattern between primary and metastatic tissues (Figure 1 ). We used VDJView to integrate immune receptor could also indicate presence of malignant immune cells as these genes are often found in leukemia and likely to contribute to oncogenesis BCL6 [19, 20] . Further analysis of this data is detailed in Supplementary Note 2.
Analysis of 10X antigen specific CD8+ T cells
To further demonstrate the utility of VDJView, we have analysed the recently published scRNA-seq data with TotalSeq and dextramer stained CD8+ T cells. This dataset contains single cell data on over 150,000 CD8+ T cells isolated from 4 healthy donors, two of which were CMV positive, 44 dextramers were simultaneously used in each subject to isolate antigen specific T cells across viral infections (CMV, EBV, HPV, Influenza, HIV), and cancer (e.g., MART, MAGE NY-ESO). We used this data to study the clonal distribution within and across specific antigens and link this information to the gene expression and other metadata.
In this analysis, we uploaded and analysed the TCR sequences and the gene expression matrices available on the 10X Genomics website. Utilising the available csv template in VDJView, we generated a third file containing the available metadata for each cell, e.g., subject ID, TotalSeq 15
surface markers including T cell differentiation markers (CD45RA, CD45RO, CCR7) and exhaustion and activation markers such as HLA-DR and PD-1, and tetramers read-counts (HLA-I restricted epitopes), MHC allele and other information. Given the large number of cells in the dataset, which can be a limitation for the standard computational resources available to the user, we used VDJView to randomly sample 15,000 cells from donor 1. We then performed quality control on the data, filtering out cells with >15% mitochondrial genes or abnormally high total expression counts, leaving 11,675 cells. After removing these obvious outliers, contaminants and poor quality cells, we filtered out cells with low tetramer read counts, or tetramer read counts that were not significantly higher than the negative control tetramers (also available in the dataset). This filtering resulted in 3,815 antigen specific T cells. We used this set to explore the distribution of genes, markers for T cell differentiation, receptor clonotype, and tetramer specificity. Unsupervised analysis (Figure 2a We then utilised the dimensionality reduction features of VDJView to further explore clonality within these subsets. We used the t-SNE plots (Figure 2b ) generated utilising the gene expression profiles to explore protein and tetramer expression, as well as other metadata information. As expected, the clusters identified via SC3 largely formed distinct clusters, with EBV and influenza specific T cells revealing the highest tetramer read counts, thus suggesting high affinity of these cells for the cognate antigens. Within the CMV and EBV specific T cells, clonally expanded T cells formed larger clusters, suggesting a common gene signature in clonally expanded populations. Interestingly, EBV and influenza tetramers, had higher read counts, suggesting that these cells might have higher binding affinities. By marking the expression of genes such as GZMH, LEF1, TCF7, CMC1 and CCR7 gene expression, the t-SNE plots revealed sub-clusters based on the differentiation status of T cells. Finally, we performed pseudo-time analysis (Figure 2c) to reveal a naïve to effector phenotype transition, shown by the increase in CD45RO expression, which is inversely mirrored in CD45RA expression.
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Frequency donor 1 and 41,723 from donor 2). Both donors displayed clonally expanded populations (Figure 3) , with 3 unique TCR expanded across at least 1,000 cells, and over 16 expanded across at least 100 cells.
Both donors displayed VDJ gene usage bias, with a relatively high usage of TRBV19 common to both donors. We identified a total of 15,600 unique TCRs, with 411 TCRs common in both donors (Table   2 shows 15 of these). We also found evidence of cross reactive TCR that target different antigens within the same species, or across species, opening further avenues of study. 
Discussion
We have shown that integrating immune receptor and gene expression data with clinical information is useful to discover novel, biologically relevant findings from published data that do not emerge through previous analyses, and to further understand and discover medically relevant mechanisms.
VDJView, a platform to conduct such analysis, forms an integrated set of known and novel tools that have a flexible design, expanding other tools and providing a robust quantitative framework to generate and study multi-omic immune cell data at the single cell level.
The proposed framework can be utilised by bioinformatics experts to develop and integrate new tools, as well as by clinical scientists and immunologists without profound knowledge of bioinformatics tools. Additionally, we propose that the software is a useful tool for lab-meetings as it promotes an onthe-go type of analysis that is suitable for quick hypothesis testing.
Limitations
VDJView is developed in R, and therefore it is relatively simple to maintain and install. However, updates to the packages that VDJView utilises may cause dependency issues or loss of function due to code deprecation. This is an issue that requires periodic updates, and while we will maintain the software, fixing any issues that arise, we recommend using the suggested R versions. Additionally, while VDJView can analyse multiple datasets at once, the software does not perform any batch correction. As such, any technical variation in the data should be corrected for prior to uploading.
VDJView will be maintained monthly and new tools will be integrated according to the development of software packages in the field, and the feedback received from users of the software.
Conclusions
VDJView is a complete software package for downstream analysis of single cell gene expression, immune receptor and metadata, which allows exploratory and hypothesis driven analysis of multiomic datasets. In summary, VDJView has the potential to allow clinical and experimental researchers to utilise complex genomics data to test biologically relevant questions.
